metsera glp 1 Pfizer to Acquire Metsera, Advancing Obesity and Cardiometabolic Treatments | Albert Bourla posted on the topic Metsera Reports Highly Competitive Results
Description
Here goes your text
These preclinical findings support clinical trial results showing that tirzepatide, a dual GIPR/GLP-1R agonist, exhibits greater anti-obesity effects than GLP-1 receptor agonists alone
The flu vaccine helps prevent serious complications and hospital stays for people with heart disease, asthma, chronic obstructive pulmonary disease (COPD), diabetes and other health issues
10.1053/j.gastro.2014.09.042 Gastroenterology 29 BathD
It presents their discovery of a GLP-1 oral solution as a turning point in their NHS routine, implying that NHS staff themselves are using the product
M.LinY.PetrouN
